Cancers

Cancers is a peer-reviewed, open access journal of oncology, published semimonthly online by MDPI. The Irish Association for Cancer Research (IACR), Spanish Association for Cancer Research (ASEICA)Biomedical Research Centre (CIBM)British Neuro-Oncology Society (BNOS) and Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) are affiliated with Cancers and their members receive a discount on the article processing charges.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
  • Journal Rank: JCR - Q1 (Oncology) / CiteScore - Q1 (Oncology)
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 17.4 days after submission; acceptance to publication is undertaken in 2.5 days (median values for papers published in this journal in the second half of 2024).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
  • Sections: published in 18 topical sections.
  • Companion journals for Cancers include: Radiation and Onco.
Impact Factor: 4.5 (2023); 5-Year Impact Factor: 4.9 (2023)
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biomedicines, Cancers, Current Oncology, Onco, Pathophysiology
Individualized Molecular Mechanisms and Treatment in Tumor Metastasis Topic Editors: Dong Tang, Chen Liu, Bin Cheng
Deadline: 5 January 2025
Topic in Antioxidants, Biomolecules, Cancers, Cells, IJMS, Pathogens
Advances in Natural Products and Phytochemicals in Cancer Prevention and Therapeutics Topic Editors: Shun-Fa Yang, Ming-Hsien Chien
Deadline: 13 February 2025
Topic in Cancers, Healthcare, Pharmaceuticals, Pharmaceutics, Pharmacoepidemiology
Advance in Cancer Pharmacoepidemiology Topic Editors: Shih-Chieh Shao, Edward Chia-Cheng Lai
Deadline: 20 February 2025
Topic in BioMedInformatics, Cancers, Cells, Diagnostics, Immuno, IJMS
Inflammatory Tumor Immune Microenvironment Topic Editors: William Cho, Anquan Shang
Deadline: 15 March 2025
Special Issue in Cancers
Monitoring Treatment Response of Biomarkers in Cancer Guest Editors: Stamatios E. Theocharis, Alexandros G. Sykaras
Deadline: 1 January 2025
Special Issue in Cancers
Advances in the Management of Prostate Cancer: New Insights into Biological and Clinical Factors Guest Editors: Mutlay Sayan, Yetkin Tuac
Deadline: 1 January 2025
Special Issue in Cancers
RAS Signaling Pathway in Cancer Therapy Guest Editor: Matthias Drosten
Deadline: 5 January 2025
Special Issue in Cancers
Anesthesia and Cancer Recurrence: A New Sight Guest Editor: Lucillia Bezu
Deadline: 5 January 2025
Topical Collection in Cancers
Emerging Therapeutics in Advanced Melanoma Collection Editors: Jeremy S. Bordeaux, Luke D. Rothermel
Topical Collection in Cancers
Neuroendocrine Tumors: Treatment and Management Collection Editor: Alessio Imperiale
Topical Collection in Cancers
New Discoveries and Future Trend for Prostate Cancer Research and Treatment Collection Editor: Zakaria Y. Abd Elmageed
Topical Collection in Cancers
Artificial Intelligence in Oncology Collection Editors: Andreas Stadlbauer, Anke Meyer-Baese, Max Zimmermann
Back to TopTop
  NODES
admin 8
Association 9
Idea 1
idea 1
innovation 2
INTERN 35
Note 8
Project 1
twitter 1